Congenital myopathies are a rare group of genetic neuromuscular diseases that are present at birth. In most cases, the cause is unknown. Symptoms typically include muscle weakness, stiffness, and joint contractures, as well as hypotonia, which can cause developmental delays. Other common features may include scoliosis, respiratory problems, swallowing difficulties, and cardiac issues. Diagnosis is often challenging as there are currently no laboratory tests or tools that can pinpoint congenital myopathies. Diagnosis often requires a combination of examinations, including physical, neurological, and musculoskeletal evaluations, as well as electrodiagnostic tests, medical imaging, and a muscle biopsy. Treatment for congenital myopathies is focused on managing symptoms and improving quality of life. It may involve physical therapy, occupational therapy, assistive devices, medications, and surgery, depending on the individual’s needs. As there is no cure, treatment plans focus on management and prevention of further complications. Although often rare, congenital myopathies can be life-threatening. Early and accurate diagnosis is critical for providing the best care possible. Fortunately, research such as whole-exome sequencing is making it possible to diagnose these conditions faster and with more accuracy. With improved diagnosis and treatment options, the quality of life for people living with congenital myopathies is improving.
Title : Novel important cellular responses, signaling mechanisms and therapeutic options in vascular dementia
Yong Xiao Wang, Albany Medical College, United States
Title : TBI updates in 2025
Jonathan Eskenazi, Cedars Sinai / UCLA, United States
Title : A case of vile vindictive primary CNS vasculitis
George Diaz, Memorial Healthcare Systems, United States
Title : Non-pharmacological strategies to counteract oxaliplatin toxicity: Protective effects of vagal nerve stimulation and resistance training on neuropathy, motor dysfunction, and muscle atrophy
Ricardo Aparecido Baptista Nucci, Hospital Sirio-Libanes, Brazil
Title : Synapticare: Integrating sleep data and tau biomarkers to assess depression severity
Medha Menon, John Foster Dulles HS, United States
Title : How have we eliminated infection: From the bone to brain?
Thomas J Webster, Interstellar Therapeutics, United States